RavenQuest issues statement in response to health Canada sales license suspension at bonify
(PresseBox) - RavenQuest BioMed Inc. (the ?Company? or ?RavenQuest?) ? (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT - http://www.commodity-tv.net/c/search_adv/?v=298617) CEO, George Robinson, also acting President & CEO at Bonify, issues the following statement in response to the February 4 Health Canada (?HC?) Notice of Suspension for Sales at Bonify Holdings Corporation (?Bonify?).
?On February 4, 2019, Bonify received a Notice of Suspension for Sales from Health Canada.hat we received in the written Notice of Suspension.
Health Canada hand delivered the Notice of Suspension at 9:30am, February 4, prior to the two-day inspection that took place on February 4-5, 2019.
Bonify initiated a recall of product and began corrective action immediately
December 11-14, 2018: HC inspects the Bonify facility
December 14, 2018: Bonify begins additional corrective actions based upon HC verbal debrief
December 21, 2018: HC reports written findings to Bonify
January 9: Bonify responds to HC?s observations
January 19: HC requests additional information with a February 1 due date, later extended to February 11 at Bonify?s request
February 4: HC delivers Notice of Suspension to Bonify prior to the Bonify facility inspection
Bonify is entitled to respond to the Notice of Suspension within 10 days and will vigorously defend its license by providing reasons why the suspension is unfounded?.
About RavenQuest BioMed Inc.
RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.
RavenQuest maintains a research partnership with Montreal?s McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.
On Behalf of the Board of Directors of
?George Robinson?
Chief Executive Officer
For further information, please contact:
Mathieu McDonald, Corporate Communications ? 1-877-282-1568
In Europe:
Swiss Resource Capital AG
Jochen Staiger
info(at)resource-capital.ch
https://www.resource-capital.ch/
Neither Canadian Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Stock Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.
Cautionary Note Regarding Forward-Looking Statements
All statements in this press release, other than statements of historical fact, are ?forward-looking information? with respect to the Company within the meaning of applicable securities laws, including statements with respect to the development of licensed cannabis production facilities, the production and supply of cannabis to the BCLDB, .the launch of consumer cannabis brands and the development of partnerships with Indigenous communities.ks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieveiffer materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.02.2019 - 02:21 Uhr
Sprache: Deutsch
News-ID 1546581
Anzahl Zeichen: 5330
contact information:
Contact person:
Town:
Vancouver, British Columbia
Phone:
Kategorie:
Internet
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 592 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"RavenQuest issues statement in response to health Canada sales license suspension at bonify
"
steht unter der journalistisch-redaktionellen Verantwortung von
Swiss Resource Capital AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
